Research Summaries

The FDA has released its recommendations—based on a report by the WHO—for the vaccine components of next year's trivalent and quadrivalent influenza vaccines.

The FDA has approved Zarxio (filgrastim-sndz), the first biosimilar product to be released in the United States, for indications including certain patients with cancer, leukemia, and neutropenia.

Researchers are developing a new peanut allergy test to determine a patient’s sensitivity to allergic reaction through a few drops of blood.

The FDA announced new label requirements for testosterone therapy drugs warning of possible cardiovascular risks.

In this commentary, the authors describe how they assessed recent Medicare access trends at a local level, specifically in a midsize metropolitan city.

Researchers approved a new combination drug for the treatment of intra-abdominal and complicated urinary tract infections.

New research examined the effect diet has on the progression of chronic kidney disease into end-stage renal disease.

The FDA has approved a new option for the treatment of individuals with symptomatic superficial varicose veins of the legs.

New research tracked levels of coffee consumption and how they related to the risk of developing multiple sclerosis.

Making improvements in HIV diagnosis and retention in care is as important as reducing high-risk sexual and drug use behaviors in terms of cutting the number of HIV transmissions in the United States,...